Theraclion is the French MedTech company behind the Sonovein®, the only non-invasive varicose vein treatment. Robotic-driven, Sonovein® is powered by High Intensity Focused Ultrasound (HIFU). It does not require incisions nor an operating room, leaves no scars, and allows patients a quick return to their daily activities. The CE-marked platform has the potential to replace millions of surgical procedures every year. In the United States, Sonovein® is an investigational device limited to investigational use; it is not available for sale in the U.S. Based in Malakoff (Paris), the Theraclion team is made up of some 30 people, most of them involved in technological and clinical development.
Looking for a particular Theraclion employee's phone or email?
Theraclion Questions
The Theraclion annual revenue was $3 million in 2026.
David Caumartin is the CEO of Theraclion.
42 people are employed at Theraclion.
Theraclion is based in Malakoff, Wallis and Futuna.
The NAICS codes for Theraclion are [33, 334].
The SIC codes for Theraclion are [38, 384].
Top Theraclion Employees
-
23
-
Alexandra Rocher
COO at Theraclion
Paris, FR1 -
22
-
25+
-
Bjoern Gerold
Head of research and hardware development at Theraclion
Île-de-France, France25+ -
22
-
1
Related Companies
